.beta.-Adrenergic blocking alkanolamine derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26050117, 424211, 424230, 424317, 424330, 564349, 564351, N61K 31135, C07C 8728

Patent

active

042750580

ABSTRACT:
1-Indanyloxy- or tetrahydronaphthyloxy-3-amino-2-butanol derivatives, especially erythro-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess peripherally-selective .beta.-adrenergic blocking activity.

REFERENCES:
patent: 3337628 (1967-08-01), Crowther et al.
patent: 3415873 (1968-12-01), Stevens
patent: 3501769 (1970-03-01), Crowther et al.
patent: 3534085 (1970-10-01), Narayanan et al.
patent: 3646066 (1972-02-01), Narayanan et al.
patent: 4029676 (1977-06-01), Hauck et al.
patent: 4048231 (1977-09-01), Hauck et al.
patent: 4127675 (1978-11-01), Murakami et al.
British J. Pharm., 1970, 39, 139, Levy et al.
British J. Pharm., 1973, 49, 514, Levy.
Fitzgerald et al., Federation Proceedings, 1975, 721.
Manufacturing Chemist, 37, p. 56 (1966).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

.beta.-Adrenergic blocking alkanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .beta.-Adrenergic blocking alkanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-Adrenergic blocking alkanolamine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2207642

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.